Troponin reporting in Australia in 2003

Annals of Clinical Biochemistry

Volumn 42, Issue 1, 2005, Pages 61-63

  Davey, Richard X ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN;

ARTICLE; AUSTRALIA; DIAGNOSTIC PROCEDURE; HEART MUSCLE NECROSIS; LABORATORY TEST; PRIORITY JOURNAL;

AUSTRALIA; BIOLOGICAL MARKERS; CLINICAL LABORATORY TECHNIQUES; CROSS-SECTIONAL STUDIES; HUMANS; MYOCARDIAL INFARCTION; QUESTIONNAIRES; TROPONIN T;

EID: 13444269011     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563053026907     Document Type: Article

References (9)

1. Nomenclature and Criteria for Diagnosis of Ischemic Heart Disease: Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59: 607-8
2. Wu AHB, Apple FS, Warshaw MM, eds. Recommendations for the Use of Cardiac Markers in Coronary Artery Disease. Washington: AACC Press, 1999
3. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/ American College of Cardiology Committee for the Redefinition of Myocardial Infarction. JACC 2000; 36: 959-69
4. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/ American College of Cardiology Consensus Recommendations. Clin Chem 2003; 49: 1331-6
5. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), (IFCC) Scientific Division Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 2002; 48: 174-178
6. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-6
7. Listed at: National Association of Testing Authorities, Australia. http://www.nata.asn.au. Accessed June 15, 2003
8. RCPA/QAPData on number of laboratories. Quoted with permission of Dr K Sikaris
9. White HD. Things ain't what they used to be: Impact of a new definition of myocardial infarction. Am Heart J 2002; 144: 933-7 (Editorial)